Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Pain Therapeutics Inc (GANX) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Pain Therapeutics Inc (GANX) lobbying for?
Summary of Lobbying Data:
– Lobbying Firms: Arnold & Porter Kaye Scholer Llp, Squire Patton Boggs
– General Issues: Medical/Disease Research/Clinical Labs, Pharmacy, Alcohol and Drug Abuse, Health Issues
– Specific Issues: Development of abuse-deterrent drug formulations, P.L. 110-85/HR 3580, and diversion, Implementation of P.L. 110-85/HR 3580, Food and Drug Administration Amendments Act of 2007 (section on post-market drug safety), misuse, Issues related to abuse-resistant drug products, Food and Drug Administration Act of 2007 (section on post-market drug safety), Prescription drug abuse
– Government Agencies: Senate, House of Representatives
Inference on why the company is lobbying:
One could infer that Pain Therapeutics Inc is lobbying on issues related to abuse-resistant drug products, prescription drug abuse, and the development of abuse-deterrent drug formulations because the company is a pharmaceutical company that specializes in pain management. Pain medications are often prone to abuse, and the company may be seeking to ensure that their products are safe and effective while also addressing concerns about potential drug abuse. Additionally, the company may be seeking to influence legislation and regulations related to the use and abuse of prescription drugs.
